This is a Validated Antibody Database (VAD) review about human LPAR3, based on 3 published articles (read how Labome selects the articles), using LPAR3 antibody in all methods. It is aimed to help Labome visitors find the most suited LPAR3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
LPAR3 synonym: EDG7; Edg-7; GPCR; HOFNH30; LP-A3; LPA3; RP4-678I3; lysophosphatidic acid receptor 3; LPA receptor 3; LPA receptor EDG7; LPA-3; calcium-mobilizing lysophosphatidic acid receptor LP-A3; endothelial cell differentiation gene 7; endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7; lysophosphatidic acid receptor Edg-7

Abcam
rabbit polyclonal
  • western blot; mouse; 1:200
Abcam LPAR3 antibody (Abcam, ab23692) was used in western blot on mouse samples at 1:200. PLoS ONE (2014) ncbi
MilliporeSigma
rabbit polyclonal
  • western blot; human; 1:500; fig 1C
MilliporeSigma LPAR3 antibody (Sigma-Aldrich, HPA013421) was used in western blot on human samples at 1:500 (fig 1C). PLoS ONE (2015) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:30
In order to evaluate the LPA-producing enzyme autotaxin and LPAR3 as potential therapeutic targets in breast cancer patients, MilliporeSigma LPAR3 antibody (Sigma-Aldrich, HPA013421) was used in immunohistochemistry - paraffin section on human samples at 1:30. Tumour Biol (2012) ncbi
Articles Reviewed
  1. Leve F, Peres Moreira R, Binato R, Abdelhay E, Morgado Díaz J. LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways. PLoS ONE. 2015;10:e0139094 pubmed publisher
  2. Knowlden S, Capece T, Popovic M, Chapman T, Rezaee F, Kim M, et al. Regulation of T cell motility in vitro and in vivo by LPA and LPA2. PLoS ONE. 2014;9:e101655 pubmed publisher
  3. Popnikolov N, Dalwadi B, Thomas J, Johannes G, Imagawa W. Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma. Tumour Biol. 2012;33:2237-43 pubmed publisher